KR940703655A - 약제학적 조성물과 그 제조방법 - Google Patents

약제학적 조성물과 그 제조방법

Info

Publication number
KR940703655A
KR940703655A KR1019940702143A KR19940702143A KR940703655A KR 940703655 A KR940703655 A KR 940703655A KR 1019940702143 A KR1019940702143 A KR 1019940702143A KR 19940702143 A KR19940702143 A KR 19940702143A KR 940703655 A KR940703655 A KR 940703655A
Authority
KR
South Korea
Prior art keywords
inhibitor
phenyl
pharmaceutical composition
mao
absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019940702143A
Other languages
English (en)
Korean (ko)
Inventor
칼만 매기야르
죠제프 가알
이스트반 스지라키
죠제프 렌지엘
스자보 안나 지
카탈린 마르마로시
이스트반 헤르메쯔
이스트반 스자트마리
졸탄 토로크
피터 코르모지
Original Assignee
기오기 블라스코·카탈린 마르마로시
치노인 기오기스제르 에스 베기에스제티 테르메케크 기아라 알티.
카탈린 마르마로시
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 기오기 블라스코·카탈린 마르마로시, 치노인 기오기스제르 에스 베기에스제티 테르메케크 기아라 알티., 카탈린 마르마로시 filed Critical 기오기 블라스코·카탈린 마르마로시
Publication of KR940703655A publication Critical patent/KR940703655A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019940702143A 1991-12-20 1992-12-18 약제학적 조성물과 그 제조방법 Abandoned KR940703655A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU914060A HUT63579A (en) 1991-12-20 1991-12-20 Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
HU4060/91 1992-12-08
PCT/HU1992/000060 WO1993012775A1 (en) 1991-12-20 1992-12-18 Pharmaceutical composition and process for the preparation thereof

Publications (1)

Publication Number Publication Date
KR940703655A true KR940703655A (ko) 1994-12-12

Family

ID=10966728

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940702143A Abandoned KR940703655A (ko) 1991-12-20 1992-12-18 약제학적 조성물과 그 제조방법

Country Status (27)

Country Link
US (1) US5589513A (cg-RX-API-DMAC10.html)
EP (1) EP0617615A1 (cg-RX-API-DMAC10.html)
JP (1) JPH07502730A (cg-RX-API-DMAC10.html)
KR (1) KR940703655A (cg-RX-API-DMAC10.html)
AU (1) AU677170B2 (cg-RX-API-DMAC10.html)
BG (1) BG98827A (cg-RX-API-DMAC10.html)
BR (1) BR9206950A (cg-RX-API-DMAC10.html)
CA (1) CA2125776A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ147494A3 (cg-RX-API-DMAC10.html)
EC (1) ECSP930933A (cg-RX-API-DMAC10.html)
EE (1) EE03015B1 (cg-RX-API-DMAC10.html)
FI (1) FI942932A7 (cg-RX-API-DMAC10.html)
HU (2) HUT63579A (cg-RX-API-DMAC10.html)
IL (1) IL104150A (cg-RX-API-DMAC10.html)
LT (1) LT3119B (cg-RX-API-DMAC10.html)
LV (1) LV10386B (cg-RX-API-DMAC10.html)
MY (1) MY111055A (cg-RX-API-DMAC10.html)
NO (1) NO942303D0 (cg-RX-API-DMAC10.html)
NZ (1) NZ246384A (cg-RX-API-DMAC10.html)
PH (1) PH31073A (cg-RX-API-DMAC10.html)
PL (1) PL172048B1 (cg-RX-API-DMAC10.html)
RO (1) RO115785B1 (cg-RX-API-DMAC10.html)
RU (1) RU2125448C1 (cg-RX-API-DMAC10.html)
SI (1) SI9200404A (cg-RX-API-DMAC10.html)
SK (1) SK74494A3 (cg-RX-API-DMAC10.html)
WO (1) WO1993012775A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA929883B (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE4432610C1 (de) * 1994-09-13 1996-02-01 Knoll Ag Verfahren zur Herstellung von Selegilin-Hydrochlorid
EP0808160A1 (en) * 1995-02-10 1997-11-26 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
JP4499208B2 (ja) 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
RU2194983C2 (ru) * 2000-06-30 2002-12-20 Научно-исследовательский институт военной медицины Способ оценки нейротоксичности сыворотки крови больных с заболеваниями печени
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
DE102009045056A1 (de) * 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Fleckenvorbehandlungsmittel
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3824296B1 (en) 2018-07-20 2026-04-01 Lipocine Inc. Oral pharmaceutical composition comprising testosterone tridecanoate and/or testosterone dodecanoate for treating liver diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
EP0241809B1 (de) * 1986-04-16 1990-08-08 ASTA Pharma Aktiengesellschaft Synergistische Kombination von Amantadin und Selegilin
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (en) * 1990-02-28 1991-08-29 Albert Walter Brzeczko Deprenyl/l-dopa/carbidopa pharmaceutical composition
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

Also Published As

Publication number Publication date
SI9200404A (en) 1993-06-30
LTIP249A (en) 1994-07-15
EE03015B1 (et) 1997-08-15
CZ147494A3 (en) 1995-01-18
CA2125776A1 (en) 1993-07-08
LV10386B (en) 1995-12-20
AU3265293A (en) 1993-07-28
AU677170B2 (en) 1997-04-17
ECSP930933A (es) 1994-04-20
HU211478A9 (en) 1995-11-28
ZA929883B (en) 1994-05-16
NZ246384A (en) 1996-02-27
HUT63579A (en) 1993-09-28
PL172048B1 (pl) 1997-07-31
BR9206950A (pt) 1995-11-28
RU2125448C1 (ru) 1999-01-27
IL104150A (en) 1997-11-20
JPH07502730A (ja) 1995-03-23
LV10386A (lv) 1995-02-20
NO942303D0 (no) 1994-06-17
FI942932A0 (fi) 1994-06-17
BG98827A (bg) 1995-06-30
SK74494A3 (en) 1995-01-12
EP0617615A1 (en) 1994-10-05
US5589513A (en) 1996-12-31
NO942303L (cg-RX-API-DMAC10.html) 1994-08-17
MY111055A (en) 1999-08-30
HU914060D0 (en) 1992-03-30
FI942932L (fi) 1994-06-17
WO1993012775A1 (en) 1993-07-08
FI942932A7 (fi) 1994-06-17
RO115785B1 (ro) 2000-06-30
PH31073A (en) 1998-02-05
LT3119B (en) 1994-12-27

Similar Documents

Publication Publication Date Title
CA1161362A (en) Pharmaceutical compositions containing a corticosteroid substance
BR0307409A (pt) Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
BR9910849A (pt) Composto, processo para a profilaxia ou tratamento de uma condição clìnica em um mamìfero, tal como um humano, formulação farmacêutica, uso de um composto, processo para preparação do composto, e, derivado protegido.
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
ES2185307T3 (es) Inhibidores de la farnesil transferasa que tienen una estructura piperidinica y procedimiento para su preparacion.
NO950774L (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
BRPI0409227B8 (pt) "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)"
ES463877A1 (es) Procedimiento para la preparacion de benzamidas y naftamidasn-(2-aminocicloalifaticas).
BR0108694A (pt) Derivados de ácido malÈnico, processo para preparação dos mesmos, uso dos mesmos como inibidor de atividade do fator xa e composições farmacêuticas que contêm os mesmos
BR112022003562A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de fibrose de órgãos
BR0316950A (pt) Derivados de indazol como antagonistas de crf
MY111055A (en) Pharmaceutical composition and process for the preparation thereof
RU2007118727A (ru) Ингибиторы mif
ES2215919T3 (es) Derivados de cumarina con actividad inhibidora de comt.
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
JPWO2023095860A5 (cg-RX-API-DMAC10.html)
NO975581L (no) Fremgangsmåte for å redusere bentap
BR0115454A (pt) Composto de 1-metilcarbapenem ou um sal ou derivado de éster deste farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto ou de um sal ou derivado de éster deste farmaceuticamente aceitável
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
NO994181D0 (no) S-2'-(2-(1-metyl-2-piperidyl)etyl)cinnamanilid som 5-HT2 reseptor antagonist
KR970701044A (ko) 콜린에스테라제 활성제
DK601683A (da) Dialkylaminoalkoxybenzylalkoholderivater
US4447449A (en) Methods of treating ischemic states
IE39679B1 (en) Methods and compositions for killing parasites of warm blooded animals
BR9916733A (pt) Derivados de arilalcanoìla, processos para sua preparação, seu uso e composições farmacêuticas que os contêm

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19940620

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19971216

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19991027

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20000724

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20010316

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee